Cargando…

LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies

Alternative splicing (AS) is a process in which precursor messenger RNA (pre-mRNA) splicing sites are differentially selected to diversify the protein isoform population. Changes in AS patterns have an essential role in normal development, differentiation and response to physiological stimuli. It is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizzacasa, Barbara, Morini, Elena, Pucci, Sabina, Murdocca, Michela, Novelli, Giuseppe, Amati, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343826/ https://www.ncbi.nlm.nih.gov/pubmed/28146073 http://dx.doi.org/10.3390/ijms18020290

Ejemplares similares

Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes
por: Pucci, Sabina, et al.
Publicado: (2019)

The human rs1050286 polymorphism alters LOX‐1 expression through modifying miR‐24 binding
por: Morini, Elena, et al.
Publicado: (2015)

Targeting LOX-1 Inhibits Colorectal Cancer Metastasis in an Animal Model
por: Murdocca, Michela, et al.
Publicado: (2019)

LOX-1 and cancer: an indissoluble liaison
por: Murdocca, M., et al.
Publicado: (2021)

Two RECK Splice Variants (Long and Short) Are Differentially Expressed in Patients with Stable and Unstable Coronary Artery Disease: A Pilot Study
por: Vancheri, Chiara, et al.
Publicado: (2021)

Urine LOX-1 and Volatilome as Promising Tools towards the Early Detection of Renal Cancer
por: Murdocca, Michela, et al.
Publicado: (2021)

Early Hippocampal i-LTP and LOX-1 Overexpression Induced by Anoxia: A Potential Role in Neurodegeneration in NPC Mouse Model
por: Lo Castro, Adriana, et al.
Publicado: (2017)

MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study
por: Rizzacasa, Barbara, et al.
Publicado: (2019)

Expression analysis of miRNA hsa‐let7b‐5p in naso‐oropharyngeal swabs of COVID‐19 patients supports its role in regulating ACE2 and DPP4 receptors
por: Latini, Andrea, et al.
Publicado: (2022)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

LOX-1: Regulation, Signaling and Its Role in Atherosclerosis
por: Kattoor, Ajoe John, et al.
Publicado: (2019)

Application of Next Generation Sequencing for personalized medicine for sudden cardiac death
por: Morini, Elena, et al.
Publicado: (2015)

The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer
por: Murdocca, Michela, et al.
Publicado: (2016)

LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy
por: Amati, Francesca, et al.
Publicado: (2012)

LOX-1: Implications in atherosclerosis and myocardial ischemia
por: Sharma, Tanya, et al.
Publicado: (2022)

Cutaneous and metabolic defects associated with nuclear abnormalities in a transgenic mouse model expressing R527H lamin A mutation causing mandibuloacral dysplasia type A (MADA) syndrome
por: D’Apice, Maria Rosaria, et al.
Publicado: (2020)

Downregulation of Circulating Hsa-miR-200c-3p Correlates with Dyslipidemia in Patients with Stable Coronary Artery Disease
por: Vancheri, Chiara, et al.
Publicado: (2023)

Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine
por: Novelli, Giuseppe, et al.
Publicado: (2023)

Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery
por: De Masi, Claudia, et al.
Publicado: (2020)

Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset
por: Di Rienzo, Carmine, et al.
Publicado: (2013)

Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress
por: Gu, Lei, et al.
Publicado: (2013)

Mutational analysis of Peroxiredoxin IV: exclusion of a positional candidate for multinodular goitre
por: Giardina, Emiliano, et al.
Publicado: (2002)

MicroRNA let-7g alleviates atherosclerosis via the targeting of LOX-1 in vitro and in vivo
por: Liu, Mingxin, et al.
Publicado: (2017)

Fisetin ameliorates atherosclerosis by regulating PCSK9 and LOX-1 in apoE(-/-) mice
por: Yan, Li, et al.
Publicado: (2021)

Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant
por: Falconi, Mattia, et al.
Publicado: (2007)

Association of Common Variants in LOX with Keratoconus: A Meta-Analysis
por: Zhang, Jing, et al.
Publicado: (2015)

Clinical Features of LMNA-Related Cardiomyopathy in 18 Patients and Characterization of Two Novel Variants
por: Ferradini, Valentina, et al.
Publicado: (2021)

Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population
por: Guo, Xin, et al.
Publicado: (2017)

SMA Human iPSC-Derived Motor Neurons Show Perturbed Differentiation and Reduced miR-335-5p Expression
por: Murdocca, Michela, et al.
Publicado: (2016)

Effects of Simulated Microgravity on Wild Type and Marfan hiPSCs-Derived Embryoid Bodies
por: Spitalieri, Paola, et al.
Publicado: (2021)

The Discovery of LOX-1, its Ligands and Clinical Significance
por: Yoshimoto, Ryo, et al.
Publicado: (2011)

Aerobic Exercise Training Inhibits Neointimal Formation via Reduction of PCSK9 and LOX-1 in Atherosclerosis
por: Li, Wei, et al.
Publicado: (2020)

The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation
por: Wang, Zhiwen, et al.
Publicado: (2022)

Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Replacing the wild type loxP site in BACs from the public domain with lox66 using a lox66 transposon
por: Chatterjee, Pradeep K, et al.
Publicado: (2010)

Protective Effects of Chinese Traditional Medicine Longhu Rendan against Atherosclerosis via Negative Regulation of LOX-1
por: Yan, Sishan, et al.
Publicado: (2018)

Screening for Novel LOX and SOD1 Variants in Keratoconus Patients from Brazil
por: Gadelha, Diego Nery Benevides, et al.
Publicado: (2020)

miR-186-5p Dysregulation in Serum Exosomes from Patients with AMI Aggravates Atherosclerosis via Targeting LOX-1
por: Ding, Jiaxing, et al.
Publicado: (2022)

Functional Analysis and Molecular Dynamics Simulation of LOX-1 K167N Polymorphism Reveal Alteration of Receptor Activity
por: Biocca, Silvia, et al.
Publicado: (2009)

COVID-19: S-Peptide RBD (484–508) Induces IFN-γ T-Cell Response in Naïve-to-Infection and Unvaccinated Subjects with Close Contact with SARS-CoV-2-Positive Patients
por: Murdocca, Michela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_go1d3bt0aqj4u7gaie8im26jla